BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25921846)

  • 1. Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study.
    de Mello VD; Lindström J; Eriksson JG; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Pihlajamäki J; Tuomilehto J; Uusitupa M
    Nutr Metab Cardiovasc Dis; 2015 Jul; 25(7):635-42. PubMed ID: 25921846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men.
    Cederberg H; Gylling H; Miettinen TA; Paananen J; Vangipurapu J; Pihlajamäki J; Kuulasmaa T; Stančáková A; Smith U; Kuusisto J; Laakso M
    PLoS One; 2013; 8(6):e67406. PubMed ID: 23840693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study.
    Takkunen MJ; Schwab US; de Mello VD; Eriksson JG; Lindström J; Tuomilehto J; Uusitupa MI;
    Eur J Nutr; 2016 Apr; 55(3):967-79. PubMed ID: 25930966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease.
    Gylling H; Hallikainen M; Rajaratnam RA; Simonen P; Pihlajamäki J; Laakso M; Miettinen TA
    Metabolism; 2009 Mar; 58(3):401-7. PubMed ID: 19217458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.
    Renner O; Lütjohann D; Richter D; Strohmeyer A; Schimmel S; Müller O; Stange EF; Harsch S
    BMC Gastroenterol; 2013 Feb; 13():30. PubMed ID: 23406058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes.
    Simonen P; Gylling H; Miettinen TA
    Atherosclerosis; 2008 Apr; 197(2):883-8. PubMed ID: 17875306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men.
    Strandberg TE; Gylling H; Tilvis RS; Miettinen TA
    Atherosclerosis; 2010 May; 210(1):282-7. PubMed ID: 19962145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes.
    Simonen P; Gylling H; Miettinen TA
    Clin Chim Acta; 2002 Feb; 316(1-2):55-61. PubMed ID: 11750274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects.
    Miwa K; Inazu A; Kobayashi J; Higashikata T; Nohara A; Kawashiri M; Katsuda S; Takata M; Koizumi J; Mabuchi H
    Clin Sci (Lond); 2005 Aug; 109(2):183-8. PubMed ID: 15816807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes.
    Simonen PP; Gylling H; Miettinen TA
    Atherosclerosis; 2007 Sep; 194(1):222-9. PubMed ID: 16963050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
    de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
    Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study.
    de Mello VD; Lindström J; Eriksson J; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Sundvall J; Laakso M; Tuomilehto J; Uusitupa M
    Diabetes Care; 2012 Feb; 35(2):211-7. PubMed ID: 22210578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.
    Hämäläinen H; Rönnemaa T; Virtanen A; Lindström J; Eriksson JG; Valle TT; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Rastas M; Aunola S; Uusitupa M; Tuomilehto J;
    Diabetologia; 2005 Nov; 48(11):2248-53. PubMed ID: 16205886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol synthesis prevails over absorption in metabolic syndrome.
    Gylling H; Hallikainen M; Kolehmainen M; Toppinen L; Pihlajamäki J; Mykkänen H; Agren JJ; Rauramaa R; Laakso M; Miettinen TA
    Transl Res; 2007 Jun; 149(6):310-6. PubMed ID: 17543849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.
    Penn L; White M; Oldroyd J; Walker M; Alberti KG; Mathers JC
    BMC Public Health; 2009 Sep; 9():342. PubMed ID: 19758428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intake of different dietary proteins and risk of type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Virtanen HEK; Koskinen TT; Voutilainen S; Mursu J; Tuomainen TP; Kokko P; Virtanen JK
    Br J Nutr; 2017 Mar; 117(6):882-893. PubMed ID: 28397639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
    Miettinen TA; Hallikainen M; Raitakari OT; Viikari J; Gylling H
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):525-31. PubMed ID: 19185477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study.
    Lehtisalo J; Lindström J; Ngandu T; Kivipelto M; Ahtiluoto S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Eriksson JG; Uusitupa M; Tuomilehto J; Luchsinger JA;
    Diabetes Metab Res Rev; 2016 Jan; 32(1):102-10. PubMed ID: 26172529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Cholesterol Sterol Concentrations as Biomarkers for Cholesterol Absorption and Synthesis in Different Metabolic Disorders: A Systematic Review.
    Mashnafi S; Plat J; Mensink RP; Baumgartner S
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.